Engineered cyanobacteria use flue gas as a CO 2 source to produce isoprene. A techno-economic analysis assesses commercial viability and determines the major cost factors influencing the overall production efficiency and scalability.
Yadav et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: